Workflow
海思科:公司首次覆盖报告:研发管线持续推进,创新转型成效显著

| --- | --- | --- | --- | --- | --- | --- | |-------------|----------|--------------------|----------|--------|-------|------------| | | | | | | | | | | | 海思科医药集团股份 | | | | | | CTR20210256 | 术后疼痛 | 有限公司 | III 期 | 已完成 | KOR | 2021-02-04 | A Clinical Trial Evaluating NCT05390905 HSK21542 in Patients for Treatment 四川海思科制药有限 Liver Disease Subjects With Pruritus A Study Evaluating the Efficacy and Safety of | --- | --- | --- | --- | --- | --- | --- | |-------------|-------|--------------------|---------|-------- ...